Literature DB >> 1129675

Pulmonary edema in patients with sepsis.

R J Finley, R L Holliday, M Lefcoe, J H Duff.   

Abstract

Fifteen critically ill patients with sepsis, 12 of whom had significant pulmonary dysfunction develop, were investigated with regard to changes in pulmonary capillary pressure, in serum oncotic pressure and on roentgenograms of the chest. It could not be shown that the pulmonary edema, which is a major characteristic of the septic lung lesion, was due to changes only in oncotic and hydrostatic pressures. Nor was there evidence that increased capillary permeability was the sole explanation of the edema. A significant relationship was found which consisted of increasing severity of the lung lesion, decreasing serum oncotic pressure and increasing pulmonary pressure. When patients with sepsis require resuscitation with fluids, the administration of moderate amounts of albumin along with monitoring of pulmonary capillary pressure appears to be a rational approach to therapy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1129675

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  4 in total

1.  Septicemia.

Authors:  T W Austin; R L Holliday
Journal:  Can Fam Physician       Date:  1976-02       Impact factor: 3.275

Review 2.  Pathogenesis of pulmonary edema associated with the adult respiratory distress syndrome.

Authors:  W J Sibbald; R R Anderson; R L Holliday
Journal:  Can Med Assoc J       Date:  1979-02-17       Impact factor: 8.262

3.  Development and Characterization of an Endotoxemia Model in Zebra Fish.

Authors:  Alan Y Hsu; Theodore Gurol; Tiago J P Sobreira; Sheng Zhang; Natalie Moore; Chufan Cai; Zhong-Yin Zhang; Qing Deng
Journal:  Front Immunol       Date:  2018-03-29       Impact factor: 7.561

4.  Meningococcal virulence in zebrafish embryos depends on capsule polysaccharide structure.

Authors:  Kim Schipper; Lisanne C Preusting; Nina M van Sorge; Yvonne Pannekoek; Arie van der Ende
Journal:  Front Cell Infect Microbiol       Date:  2022-09-23       Impact factor: 6.073

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.